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Abstract Research among African-Americans indicates
this population perceives sickle cell (SCD) to be a serious
disease and sickle cell trait (SCT) screening an important
intervention. However, studies have consistently demon-
strated a lower than desired uptake of SCD education,
inadequate knowledge regarding personal and family trait
status, and a low perceived susceptibility of giving birth to
a child with the disease. We examined general attitudes and
beliefs regarding genetics and genetic testing including
prenatal testing and newborn screening; we used this
information as the foundation to more specifically assess
attitudes and beliefs regarding SCD and perceived barriers
to SCD education and awareness. Thirty-five African-
American adult men and women participated in one of
four focus groups. Thematic analysis identified that both
prenatal testing and newborn screening are acceptable
forms of genetic testing. Based largely on their personal
experiences, participants possessed an understanding of the
natural progression of SCD but had a limited understanding
of the inheritance and probable risk of giving birth to a
child with the disease. Barriers to education and greater
awareness of SCD were classified as personal, familial, and
societal. Community based interventions focused on shar-
ing the stories of individuals with first-hand experiences
with SCD should be considered.
Keywords Sickle cell disease . African-American . Health
belief . Qualitative research . Thematic analysis . Genetic
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Introduction
Sickle cell disease (SCD) is an autosomal recessive genetic
condition that results in red blood cells with a characteristic
sickle shape. Mutations in the HBB gene are responsible for
causing the known forms of SCD including hemoglobin SS
disease, SC disease, SD disease, and the two forms of
sickle beta-thalassemia, HbSβ+ and HbSβ0 (Richer and
Chudley 2005; Wethers 2000a, b; Wilson et al. 2003).
Hemoglobin S and other abnormal beta-globin chains
create a brittle consistency that is easily lysed and more
capable of adhering to the endothelial cells of the vascular
system. The pathogenic process begins when the sickled
hemoglobin is polymerized as a result of deoxygenation
leaving the red blood cell to become dehydrated and
deformed. It is this red blood cell that can adhere to the
vascular endothelium. As a result, individuals with SCD
can experience hemolysis, anemia, pain episodes, swelling,
and vascular occlusion potentially leading to ischemic
attacks and organ damage (Richer and Chudley 2005;
Wethers 2000a, b; Wilson et al. 2003).
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Sickle cell disease is a pan-ethnic condition with the
highest prevalence among those of African, Mediterranean,
Middle Eastern, Indian, Caribbean, and Central and South
American descent (Wethers 2000a, b; Wilson et al. 2003).
Every 1 in 12 African-Americans has sickle cell trait (SCT),
and the disease affects 1 in 375 African-Americans (Richer
and Chudley 2005; Wethers 2000a, b).
The first statewide newborn screening program for SCD
was initiated in New York in 1975. However, it was not
until 1986 that studies were published demonstrating the
benefit of prophylactic penicillin to prevent infection and
early death in children with SCD. In 1996, the American
Academy of Pediatrics recommended every state implement
targeted newborn screening for hemoglobinopathies and
currently, all states screen for this class of conditions (Olney
2000). Newborn screening for hemoglobinopathies includ-
ing SCD is performed by isoelectric focusing in the
majority of screening programs; however, some states
utilize high performance liquid chromatography in con-
junction with isoelectric focusing. The purpose of newborn
screening for SCD is to identify affected individuals but
due to test methodology, SCT can be detected as well.
Because identification of SCT is not the objective of
screening, some laboratories do not report these results.
When a diagnosis of SCD is made, prophylactic penicillin
is recommended to be administered by 2 to 3 months of age
in order to reduce the incidence of pneumococcal sepsis
(Pass et al. 2000).
Uptake of Sickle Cell Disease Education and Genetic
Counseling Following Identification of Trait
Few states have aggressive follow-up programs or staff
devoted to SCT follow-up after the identification of trait by
newborn screening. However, those programs designed to
offer genetic counseling and follow-up have met with
limited success and uptake by parents and families. In a
2000 report from the National Newborn Screening and
Genetics Resource Center (2009), only 15% of the 50,491
infants identified with SCT had confirmatory testing, and
the resulting uptake of family counseling and testing is
unknown (Kladny et al. 2005).
A 2005 study by Kladny and colleagues examined SCT
follow-up and genetic counseling pre and post implemen-
tation of an intensive follow-up protocol for infants with an
abnormal hemoglobinopathy trait identified by newborn
screening. Between 1997 and 2002, families were notified
of their infant’s SCT status by mail and offered genetic
counseling. Only 5.3% of those families received genetic
counseling by telephone, and 2% underwent extended
family member testing. In 2003 an intensive follow-up
protocol was implemented including letters, telephone calls,
educational videos, and the possibility of providing genetic
counseling over the phone or in person. In 9 months
following the start of this protocol, 52% of families were
reached by telephone. Of these families, 92% accepted
genetic counseling by telephone and 12% scheduled an
appointment for genetic counseling in person. This inten-
sive follow-up significantly improved acceptance of SCD
genetic counseling. However, few states support this type of
program. In a 2009 report from the National Newborn
Screening and Genetics Resource Center (2009), only 12 of
50 states (24%) have what they label as an “aggressive
follow-up protocol” for SCT. Without this type of follow-up
in place, the uptake of SCD education and genetic
counseling remains lower than desired even among those
families who have a child identified to have SCT. There still
remains a significant portion of parents and families who do
not receive information about the inheritance of SCD, and it
is assumed that many do not understand the risks to future
children and grandchildren.
Knowledge and Perception of Sickle Cell Disease
A limited number of studies have been conducted to
examine African-Americans’ knowledge and perception of
SCD, SCT, personal and family trait status, and newborn
screening for SCD. These studies have consistently dem-
onstrated a significant lack of awareness regarding the
difference between disease and trait status and how trait
status increases the chance to have a child with disease
(Acharya et al. 2009; Gustafson et al. 2007; Kladny et al.
2005; Midence et al. 1994; Treadwell et al. 2006; Wright et
al. 1994). A 2006 study by Treadwell and colleagues
examined knowledge and misconceptions about the disease
among African-American community members in a large
metropolitan area. Survey results determined only 15.9% of
individuals knew their trait status and of those, 53% learned
their trait status through discussion with family members.
Respondents who received information from friends and
family were three times more likely to know their trait
status, demonstrating the potential benefit of family
discussions about sickle cell.
Similarly, Acharya and colleagues (2009) found that
among parents with a child identified with SCD or SCTand
parents known to have SCT, the majority were knowledge-
able of their own SCT status. Only 6% of participants
surveyed did not know their SCT status. The majority of
participants learned their SCT status during prenatal
screening or positive newborn screening, and those with
an affected child cited pediatricians and SCD clinic staff as
the most common sources of sickle cell information.
Parents who did not have a child with SCD cited family
members as their most common source for this type of
information. Collectively, participants had a significant
misunderstanding of sickle cell inheritance. However,
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parents of an affected child who had an opportunity to meet
with SCD physicians and clinic staff had a greater
understanding of inheritance when compared to those
without an affected child, highlighting the value of personal
conversations with healthcare professionals.
Given the presence of significant misconceptions, some
research has been done to elucidate potential barriers to the
understanding of SCD. In focus groups conducted by
Treadwell and colleagues (2006), participants discussed
follow-up counseling for SCT detected by newborn
screening, described their understanding of SCD, and
suggested possible solutions for poor follow-up rates for
SCT counseling. Common themes among community
members who participated in these focus groups included
limited visibility of SCD and SCT and the need to use
media to promote awareness. Participants discussed the
stigma associated with any type of disease in the African-
American community and the need for health care
professionals to have compassion and cultural sensitivity
when discussing sickle cell. In contrast, Acharya and
colleagues (2009) found that among adults with SCT all
either disagreed or strongly disagreed with the statement “I
worry about people discriminating against me.” These
researchers were unable to demonstrate significant stigma
attached to SCT.
Gustafson and colleagues (2007) examined African-
Americans’ knowledge and perceptions of sickle cell
screening and counseling by surveying health beliefs
among African-American women. The survey design and
analysis were based on the Health Belief Model, which is
grounded in the idea that a health prevention or screening
behavior will only occur when an individual believes the
health concern is serious enough to warrant screening, he or
she is at risk of the disorder, there is a benefit to pursuing
the screening and the barriers to pursuing screening are low
(Janz and Becker 1984). The study found among African-
American women of childbearing age there is a good
understanding of the severity of SCD, high perceived
benefit of genetic testing and counseling, and low perceived
barriers to obtaining this testing.
As with previous research however, the results indicated
a low perceived personal risk to have a child with SCD.
The authors suggested that a low perceived susceptibility is
one potential explanation for the poor uptake of genetic
testing and counseling. Although perceived susceptibility
did not correlate with knowledge of SCD, participants with
an understanding of recessive inheritance did demonstrate a
higher perceived susceptibility to have a child with SCD.
Additionally, an increased level of average SCD knowledge
was found to be significantly related to a high perceived
severity of SCT and to the perceived benefit of SCT
screening. The authors suggested that participants with
personal experiences or relationships with individuals or
families affected by SCD will know more about SCD and
its severity which may cause them to believe screening is
more beneficial for reproductive planning. Based on their
findings, the authors recommended that additional research
be conducted to examine why African American women do
not believe they are at risk to have a child with SCD.
Attitudes Toward Genetic Testing
The high degree of perceived benefit from genetic testing
and counseling for SCD identified by Gustafson and
colleagues (2007) is of significance given that several
research studies examining the general attitudes and beliefs
of African-Americans toward genetic testing have found
participants hold both serious concerns and positive beliefs
about the benefits of testing. Studies conducted among
individuals in clinical, educational, and community settings
consistently demonstrate that minority participants describe
considerable risks associated with genetic testing including,
but not limited to, the possible misuse of genetic informa-
tion for the purpose of racial discrimination. However,
minorities also describe benefits of genetic testing for
prevention of disease (Catz et al. 2005; Kessler et al. 2005;
Laskey et al. 2003; Zimmerman et al. 2006).
Catz and colleagues (2005) examined attitudes toward
genetic topics among minority populations recruited from
community health centers. Of the 55 participants, 15 were
African-American and comprised two focus groups. The
greatest percentage (35%) of minority participants could
not provide any information when asked what they had
heard about genetic testing. When asked more specifically
about newborn screening, 45% were not aware that it is
routinely performed. The most commonly mentioned
genetic test by African-Americans was amniocentesis to
detect abnormalities in the fetus. The majority of minority
participants articulated the main benefit of genetic testing to
be prevention of, or preparation for disease. However,
participants also listed concerns for the unethical use of
testing, anxiety from test results, and false reassurance from
negative results. Newborn screening was viewed as a
method to prepare for a child’s health problems. However,
African-Americans and other minority participants
expressed practical concerns about the outcome of genetic
testing through newborn screening including apprehension
about insurability, financial burdens, parenting responsibil-
ities for a sick child, and the potential to test positive for a
disease with no cure.
In contrast to the study by Catz and colleagues (2005)
which examined attitudes toward genetic testing among
minorities with a range of educational levels, Laskey and
colleagues (2003) pursued similar questioning among
African-American college students in a premedical pro-
gram. These undergraduates also stated that genetic testing
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could benefit individuals/families by allowing for preven-
tion or preparation. However, the group’s overall concerns
about the risks of genetic testing were more theoretical in
comparison to the responses obtained by Catz and
colleagues. Concerns about genetic testing included risk
of genetic discrimination, increasing abortion rates, eugen-
ics, and breach of confidentiality.
Sickle Cell Disease and Genetic Discrimination
Genetic discrimination is a well documented fear among those
considering genetic testing, but few studies have been
performed examining the current prevalence of insurance,
employment, or other forms of discrimination among those
with SCD or SCT. As described in a report by The New York
State Task Force on Life and the Law (2000), in 1971 a
national, government supported program for sickle cell
disease was established. As a result, several states enacted
laws mandating African-Americans undergo sickle cell
screening, and in some states, marriage licenses and school
attendance could be denied based on refusal of screening.
Physician education on the topic was poor, and the rapid rush
to screen increased the opportunity for misunderstandings
about the disease. The distinction between affected and trait
status was not clearly articulated by screening programs, and
initial testing methodology did not distinguish between SCD
and SCT. Additionally, inaccurate information claiming
shortened life expectancy among those with SCT was
perpetuated by some medical reports. These errors led to
health and life insurance discrimination, as well as, employ-
ment discrimination and perceptions by some in the African-
American public that screening programs were eugenic in
nature. Efforts were made to correct program mistakes, and
the 1980s brought revision of state screening laws, more
reliable testing methods, and improved education programs.
More recently, Kass and colleagues (2007) specifically
compared the health insurance experiences, attitudes, and
beliefs of individuals with genetic conditions to those with
or at risk for other serious medical conditions in order to
better define the extent, if any, of insurance discrimination
against those with genetic conditions. Ninety-nine of 597
interviews were with adults with SCD or parents of children
with SCD. Results indicated that those with SCD and cystic
fibrosis were two times as likely to report having been
denied health insurance compared to those with non-genetic
conditions adjusting for age, income, marital status, race,
and employment status. Additionally, when transitioning
from being uninsured to obtaining insurance, study partic-
ipants with SCD or HIV were least likely to report having a
choice of insurance plans. These results possibly indicate
that those with a diagnosis of SCD may be experiencing
greater rates of genetic discrimination in the form of health
insurance discrimination.
Purpose of the Present Study
It is generally understood that past experiences, attitudes,
and beliefs influence the way individuals approach new
information, learning, and decision-making (Catz et al.
2005). As described previously, research among African-
Americans indicates this population perceives SCD to be a
serious disease and SCT screening an important interven-
tion. However, studies have consistently demonstrated a
lower than desired uptake of SCD education, inadequate
knowledge regarding personal and family trait status, and a
low perceived susceptibility of giving birth to a future child
with the disease. We have chosen to examine general
attitudes and beliefs regarding genetics and genetic testing
including prenatal testing and newborn screening among a
unique sample of African-American adults and use this
information as the foundation to more specifically assess
attitudes and beliefs regarding SCD and perceived barriers
to SCD education and awareness.
Methods
Participants
Study participants included African-American men and
women 18 years and older recruited from the Healthy Black
Family Project (HBFP), a community based health promo-
tion and disease prevention program located in racially
segregated neighborhoods characterized by poverty and
chronic diseases. Participants were invited to participate in
an anonymous survey and focus group. The study and all
materials were approved by the University of Pittsburgh
Institutional Review Board. The HBFP was established in
2005 by the Research Center of Excellence in Minority
Health Disparities (RCEMHD) at the Graduate School of
Public Health, University of Pittsburgh. A detailed descrip-
tion of the HBFP population (N=7,000) and intervention
components are described elsewhere (Thomas and Quinn
2008). Members typically reside in the predominately
African-American communities of Pittsburgh which sur-
round the Kingsley Association, a community recreation
and human service center which serves as the HBFP
headquarters (Vogel et al. 2007). Study participants were
recruited using culturally tailored flyers distributed at the
Kingsley Association and in monthly HBFP membership
mailings. Study participants were also recruited from the
Minority Research Recruitment Database (MRRD) estab-
lished by the RCEMHD using a telephone script. The
MRRD is a voluntary database composed of individuals
who provided informed consent to receive information
about research including clinical trials (Vogel et al. 2007).
In the present study, at the time of recruitment, participants
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were notified that focus groups would require approxi-
mately 2 h of time, and they would receive refreshments
and a $25 gift card to a local grocery store. Participants
were not required to sign a consent form by the
Institutional Review Board but were informed about the
nature of the study via an introductory script.
Instrumentation and Procedures
Four focus groups were conducted at the Kingsley
Association. Each group was held in a community room,
and participants sat together at a common table with the
focus group moderator for discussion. Audio recordings of
the focus groups were collected for later transcription and
participants chose an alias to use during discussion. There
was one moderator and one assistant to the moderator who
conducted each of the four focus groups. Both the
moderator and assistant to the moderator were genetic
counseling graduate student researchers with the HBFP and
had the opportunity to previously interact with several of
the focus group participants during other HBFP activities.
Focus groups were conducted according to a moderator’s
guide (See Appendix) and notes of the discussion were
taken by an assistant to the moderator.
Participants were asked to complete an anonymous
survey designed to characterize demographics and experi-
ence with SCD and SCT. The survey consisted of 19
questions and took approximately 10 min to complete (See
Appendix). Section one contained demographic questions
and questions regarding genetics knowledge, personal
health, and health insurance status. This section of the
survey is part of a standard survey previously utilized for
other HBFP activities and research studies. Section two was
comprised of questions regarding the participants’ familiar-
ity with SCD and SCT and knowledge of personal and
family trait status.
Data Analysis
Survey results were analyzed using descriptive statistics.
Frequencies, means, medians, and ranges were calculated,
as appropriate for major survey items.
Focus group audio tapes were transcribed by an
employee of the RCEMHD who was not directly
involved in this research study. Transcription adhered to
participants’ grammar, pauses, place holders, and unfin-
ished sentences. Each transcript was read twice by a
coder to gain familiarity with the data, and the audio
tapes were listened to once while reading each transcript
to ensure accuracy. The coder, who was also the
moderator for this study, analyzed all data; however,
transcripts and coding were reviewed regularly with
members of the research team to attempt to limit bias.
Transcripts were uploaded into QSR NUDIST VIVO®, a
software program designed to manage and facilitate
analysis of qualitative data. Transcripts were analyzed
using qualitative thematic analysis with an inductive
approach utilizing both interpretive and explicit themes
(Beeson 1997; Braun and Clarke 2006; Sandelowski
2000). Codes were generated to reflect the participants’
views and opinions and revised throughout the process in
order to better refine and capture participants’ beliefs.
Each transcript was coded for interesting features and data
were collated for each code. The codes were then searched
for common themes and comparison of codes across
transcripts enabled the identification of themes summariz-
ing the views of multiple individuals. The coder used these
themes to go back and determine if participant responses
across transcripts were accurately represented by these
themes.
Based on the data analysis, the qualitative data was
organized into five main topics: attitudes and beliefs about
genetics, attitudes and beliefs about prenatal testing,
attitudes and beliefs about newborn screening, attitudes
and beliefs about sickle cell, and barriers to education and
awareness of sickle cell. Each of these main topics was
further broken down into sub-topics as they emerged from
analysis of the data. Specific themes within each of these
sub-topics were identified from the participants’ responses.
In some cases, a particular theme was consistently
expressed across multiple sub-topics.
Results
Survey Responses
Thirty-five individuals completed the pre-discussion survey
and participated in one of four focus groups. The four
groups consisted, respectively, of 11 females; 6 females;
8 females and 2 males; and 7 females and 1 male. Table 1
contains a summary of participant demographics. The mean
age of participants was 53 years (median = 57 years; range:
26–77 years). Of these individuals, the vast majority were
female (91%) and African-American (91%). However, all
individuals who participated in the focus groups were
members of the HBFP and self-identified as African-
American or mixed ancestry including African-American
heritage. Approximately 82% of participants had children.
The most prevalent income level was between $20,000 and
35,000 (32%), and the most prevalent educational level was
1–3 years of college or technical school (40%). At the time
of data collection, the US poverty threshold for a family of
four was approximately $19,806 and the poverty level for a
family of two was approximately $13,078 (US Census
Bureau 2005).
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When asked about personal health, 57% indicated they
are in good health, 54% believed themselves to be
overweight, and 17% were smokers (Table 1). Approxi-
mately 97% reported having a form of health insurance,
57% had one personal physician, and 17% indicated they
could not go to the doctor within the last year because of
cost.
Participants’ ratings of genetics knowledge and
familiarity with SCT and SCD revealed that a majority
of individuals believe they have a fair knowledge of
genetics (47%) and a majority indicated they know
someone with SCT (64%) and someone with SCD
(64%) (Table 2). Of those individuals who reported
knowing someone with SCT or SCD, 20% also
indicated knowing an individual who was found to
have trait or disease by newborn screening. Forty-two
percent of participants acknowledged knowing their
own SCT status. For those individuals with a spouse
or partner (n=26), 26% reported knowing that individu-
al’s SCT status. Among participants with children (n=28),
40% indicated knowing their child or children’s SCT
status.
Themes in Focus Group Responses
Themes were identified by collective analysis of all four
focus group sessions (Krueger and Casey 2000). All themes
were identified in each of the four groups. Individual
comments from focus group participants were selected to
illustrate the theme described.
Topic: Attitudes and Beliefs about Genetics
Sub-Topic: Primary Source for Information about Genetics
Familiarity
Participants identified the following primary resource(s) for
obtaining information about genetics: high school and
college coursework, experiences on the job or as a
participant in research studies, physicians, the media
(internet, newspaper, magazines, and television programs
including those for entertainment, health and science
information, and news), family, and friends. In general,
participants valued a particular individual or source as a
resource because of an association with the medical
profession and a feeling of familiarity and trust. The
importance of family and friends as primary resources for
health/genetic information was highlighted over the course
of focus group conversations and is captured in the
following quotes:
I think that is true that the black community will have
someone that works at a hospital or has been at a
Table 1 Demographics of focus group participants
Demographic variable % n
Sex (n=35)
Male 8.6 3
Female 91.4 32
Ethnicity (n=35)
Hispanic 0.0 0
Not Hispanic 100.0 35
Race (n=35)
White 0.0 0
Black or African-American 91.4 32
Asian 0.0 0
Native Hawaiian or Pacific Islander 0.0 0
American Indian, Alaska Native 0.0 0
Other 8.6 3
Total Household Income (n=34)
Less than $10,000 8.8 3
$10,000–$20,000 23.5 8
$20,001–$35,000 32.4 11
$35,001–$50,000 17.6 6
$50,001–$75,000 11.8 4
Greater than $75,000 5.9 2
Education (n=35)
Elementary 0.0 0
Some high school 0.0 0
High school graduate 28.6 10
Some college or technical school 40.0 14
College graduate or post graduate 17.1 6
Masters or PhD 14.3 5
Personal Health Rating (n=35)
Excellent 2.9 1
Very Good 11.4 4
Good 57.1 20
Fair 25.7 9
Poor 2.9 1
Personal Weight (n=35)
Underweight 0.0 0
Healthy weight 25.7 9
Overweight 54.3 19
Obese 20.0 7
Smoking Status (n=35)
Smoker 17.1 6
Non-smoker 82.9 29
Health Insurance Coverage (n=35)
Yes 97.1 34
No 2.9 1
Don’t know 0.0 0
Personal Physician (n=35)
Yes, only one 57.1 20
More than one 40.0 14
No 2.9 1
Don’t know 0.0 0
Could Not See a Doctor due to Cost in Past Year (n=35)
Yes 17.1 6
No 82.9 29
Don’t know 0.0 0
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hospital for a long period of time and by that I mean
my sister. She’s 72 and we consider her the physician
of the family. She has the PDR’s [Physician’s Desk
Reference]. She’s had a long experience with different
illnesses and various things. My girlfriend she’s
worked at [Name of Hospital] for 25 years. When I
want a specialist, I go to her but that is the way I think
it happens. I think in the black community too, is that
word of mouth. (Female)
I have a friend who is a physician’s assistant, so every
now and then we’ll have like a woman session…We
just get together every now and then for fun, but if
there is anything we need to discuss, we ask her.
(Female)
Sub-Topic: Definition of Genetics
Inheritance
The majority of individuals framed their understanding of
genetics within the context of inheritance or “traveling
down the line from generation to generation (Female).”
There were some individuals who expressed a feeling that
genetics is inescapable and that the health of past relatives
has an effect on the current individual. Participants stated
that “Inheritance is something that you are born with
(Female).” and “…Your chromosomes, the X and Ys and
then that determines certain elements (pause) if you have
pre diagnosis history (Females).”
Influenced by the Environment
In contrast, there were participants who discussed how
genetics can be shaped by environmental influences such as
nutrition or how a mother’s health can impact the outcome
of a pregnancy.
Defined by Scientific Terms
It was common for study participants to use scientific or
technical language such as “genes” and “DNA” to describe
what genetics means to them. For example, as one
participant stated, “When a child is born you get DNA
from your parents, mother and father, and of course, your
DNA is made up of all the past DNA and so you get half
and half and you are who you are (Female).”
Defined by the Media
Some individuals described genetics by using popular
media stories such as actor Michael J. Fox and stem cell
research or media icon Oprah Winfrey and her tracing
African heritage television series.
Topic: Attitudes and Beliefs about Prenatal Testing
Sub-Topic: Definition of Prenatal Testing
Participants were able to correctly identify methods of
and indications for prenatal testing. Within each focus
group, there were individuals who had recently under-
gone prenatal testing or knew a friend or family member
who had used prenatal testing. Participants identified
ultrasound, amniocentesis, and viral studies as prenatal
tests but did not explicitly use these words. A young
Table 2 Focus group participants’ experience with SCT and SCD
Question % n
Knowledge of Genetics (n=34)
Excellent 0.0 0
Very good 8.8 3
Good 38.2 13
Fair 47.1 16
Poor 5.9 2
Know Someone with SCT (n=34)
Yes 64.7 22
No 29.4 10
Don’t know 5.9 2
Know Someone with SCD (n=34)
Yes 64.7 22
No 35.3 12
Don’t know 0.0 0
Know Someone with SCT/SCD Identified by NBS (n=34)
Yes 20.6 7
No 64.7 22
Don’t know 14.7 5
Knowledge of Personal SCT Status (n=33)
Yes 42.4 14
No 51.5 17
Don’t know 6.1 2
Knowledge of Partner’s SCT Status (n=34)
Yes 20.6 7
No 47.1 16
Don’t know 8.8 3
Not applicable 23.5 8
Do You Have Children (n=34)
Yes 82.3 28
No 17.7 6
Knowledge of Child(ren)’s SCT Status (n=27)
Yes 40.7 11
No 55.6 15
Don’t know 3.7 1
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woman referred to amniocentesis as “Being tested while
you are pregnant with the long needle thing in your
stomach.” When identifying the types of prenatal tests
available, participants’ responses included testing for
chromosomal conditions and single gene conditions.
Individuals mentioned chromosome testing for Down
syndrome most frequently. “I always think of chromo-
somal problems like Down syndrome and different
problems that happen when you are pregnant and they
can tell through prenatal testing (Female).” Attention was
paid to SCD as a condition potentially tested for
prenatally. “A lot of black kids have sickle cell; they
might be able to detect that (Female).”
Sub-Topic: Potential Benefits of Prenatal Tests
Value of Awareness
Participants identified awareness as a benefit of having
information about a pregnancy. Some believed this
awareness would ultimately benefit the pregnancy and
the baby while others discussed how this awareness
would benefit the mother or the family. Several partic-
ipants brought up the potential to correct a health
problem that is identified prenatally: “Can’t they do
surgery while the baby is inside? They may find
something in order to help the baby before they come
out (Female).” Another participant stated prenatal testing
was performed “to see what they can try and fix
(Female).” Some individuals felt a health problem
identified prenatally would allow the child to receive
the appropriate care in the newborn period:
When you find out through prenatal testing something
is wrong with that child and that child is born, then
you know before you leave the hospital you can treat
things so much differently-even different formulas
and stuff. If you have a child with different types of
diseases or something, you have to be very careful
with [that child]. So if you know beforehand, then
you don’t make the mistake of hurting your own child
from not knowing. (Female)
Awareness of a genetic condition during the prenatal
period can also benefit the mother and the family. For some
participants, awareness of a genetic condition allows the
mother to be knowledgeable about possible recurrence and
in select cases, make changes to lower the chance of
recurrence. One woman described how parental awareness
could help prevent spina bifida:
You could probably take that information to your next
pregnancy. When you get pregnant again, if your
body was too low with a certain vitamin or some type
of nutrition you didn’t have while you were pregnant,
you could try to boost up on that before you get
pregnant the next time so you won’t have to face any
difficulties or anything like that.
Value of Choice
Participants described choice as deciding between the
option of abortion versus the option of continuation of a
pregnancy when prenatal test results indicate the child
would have a genetic or other debilitating condition. One
woman felt that prenatal testing is performed “to see if there
is any deformity in the child and then it gives the mother
the right to say whether or not she wants to go full term.”
Another participant stated:
There also are certain diseases that run in certain races
and so this kind of testing while the baby is still in
utero can help identify them. For instance, Tay-Sachs
is a disease that runs in certain groups of people and
retardation and certain things like that. So if you
know in the first term, then the doctor will say to you,
you can make a decision at this time to go forth to go
full term or you can terminate therapeutically at this
point in time. So that’s one very good reason why
genetic testing in terms of prenatal is so important.
(Female)
The value of choice in assessing whether or not an
individual or couple will be able to care for a child with a
genetic health condition was also identified.
…Sometimes too they can detect different birth
defects before the person is full term to see if that
person is able to take that child because the child is
going to come deformed or something or maybe it’s
better medically to abort that child. (Female)
However, no participant mentioned specific social or
financial situations which would cause a person to choose
to terminate a pregnancy.
Sub-Topic: Potential Concerns or Risks of Prenatal Tests
Miscarriage
When asked to identify potential risks of prenatal testing,
many made statements such as “You could have a
miscarriage (Female).”
Relationship Stress
Participants cited concern about the impact of prenatal test
results on family relationships. One participant characterized a
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possible interaction between a couple experiencing the
process of prenatal testing:
[Prenatal testing is performed]…To see if there is
any deformity in the child and then it gives the
mother the right to say whether or not she wants to
go full term because it may be traumatic to raise a
child with special needs. So they [doctors] tell them
to have a conference to decide what they want to
do and sometimes doing that it will split up a
family because mom says, ‘I’m having my child I
don’t care what is wrong.’ and dad is like, ‘I’m not
putting up with a child that has some special
needs.’ and so now you don’t have a dad in the
picture because he just felt he can’t handle that kind
of situation, and so a lot of women won’t take it.
They’ll just say ‘We’ll find out what happens when
the child gets here’. (Female)
Personal Stress and Inability to Cope
For some individuals, the detection of a health problem in a
pregnancy could cause overwhelming stress, and they
would prefer to be unaware of a problem throughout the
course of the pregnancy. These individuals conveyed a
sense of their personal limitations in managing stress.
I think if you know that you are not going to
terminate the child and then you know there is
something wrong with it, it could be real stressful
for you, which would also be a problem for the baby.
So if you are going to do it, I think you should decide
before that if you do want to terminate it, but if you
don’t, I don’t think you really should know ahead of
time. (Female)
When I was trying to get pregnant, my husband and I,
we had a very difficult time getting pregnant, so then
they say once over 40 if you get pregnant you may be
more at risk. So then they were going to test, and I
said if I am not going to terminate, why would I want
to test because it will just make me more anxious to
have another miscarriage. (Female)
Test Limitations
Participants voiced concern about the limitations of prenatal
tests and the stress which emerged from these limitations.
That is the only thing I didn’t like about the prenatal
testing. You had to wait and after the baby came out more
testing was done, and none of the results were true
because the sonograms weren’t really efficient. They
could see some degree of the child, but they are not really
that great, so it was like I am more worrying. (Female)
Topic: Attitudes and Beliefs about Newborn Screening
Sub-Topic: Knowledge of Newborn Screening
Unaware
When asked to describe newborn screening, the vast
majority of focus group participants did not respond or
made movements such as shoulder shrugging to indicate
uncertainty. Common responses indicated a lack of aware-
ness such as “Never heard the phrase [newborn screening]”
and “So is this [newborn screening] something new? I
mean, how recent?”
Incomplete Information
Some participants articulated correct information about
newborn screening but were missing some general facts
about the process and the purpose for this testing.
Specifically, individuals correctly believed sickle cell,
cystic fibrosis, and phenylketonuria are screened for in the
newborn period. However, none of these individuals
identified that newborn screening is a heel-stick blood test
performed in the first days of life in order to detect or alter
the outcome of a disease.
Misinformation
Several participants indicated blood type, heart murmur,
diabetes, prenatal drug exposure, jaundice, and asthma are
conditions tested for by newborn screening.
Sub-Topic: Benefits of Newborn Screening
After the moderator shared a common definition for
newborn screening, participants identified potential benefits
of treatment including themes of preparation and treatment.
Preparation
Individuals expressed a desire to have the information
gathered from newborn screening to prepare to care for the
child in an appropriate way. One mother discussed the
importance of knowing her child had glucose-6-phosphate
deficiency or G6PD in order to protect him from substances
which could aggravate his condition.
I adopted my son, and when he was an infant, he had
G6PD; something I knew nothing about. So it was
good to know that and to have that information from
the hospital. I know what not to have around him,
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what not to give him especially like aspirin, and no
mothballs around him. Because my mom is from the
“old school,” she used to have mothballs, so I was
real glad that I knew.
Another participant focused on the value of knowledge
and the sense of security from being aware of a child’s
genetic condition. “You need to know what to look for. If
it’s there, if something happens, you need to know what
you’re dealing with (Female).” There were also participants
who valued advance knowledge to prepare the appropriate
services for a child in order to maximize his/her potential.
For example, “I think to get as much early intervention as
possible to help the child in ways that the child could be
stimulated (Female).”
Treatment
The possibility for early treatment when a condition is
identified by newborn screening was also explored by
participant discussion. “I know you can test for a lot of
conditions that can be treated within the first 3 months [of
life]. You can give medication to the baby to be okay
(Female).” The theme of early treatment to improve the
outcome for a child with a serious condition is also evident
in the following comment:
…And with cystic fibrosis at least they can start a
plan of treatment so the child can have a productive or
as much of a productive life as possible, as opposed to
finding out when they’re older, and you’re starting
from scratch when you could have prevented some-
thing. It’s the same thing for a child that is diagnosed
with autism. If it’s further down the road, then you’re
behind the eight ball. Whereas if you find out early
enough, you can start doing things to help get the
child in the right direction and get them into the
mainstream. (Female)
Topic: Attitudes and Beliefs about Sickle Cell
For each of the sub-topics under the general topic of
knowledge of SCD, the theme of reliance on personal
experiences was pervasive. Included under each sub-topic
is a description of how this theme was demonstrated.
Sub-Topic: Understanding of Symptoms
Participants referred to watching an acquaintance, family
member, or friend living with SCD or SCTwhen describing
features of the condition. One woman described what she
has learned about pain crises from talking with a co-worker:
I have a friend, she is a co-worker, and she has a
daughter who has it. She has a son, but he doesn’t
have it. Her daughter has had it since birth, and what
I’ve noticed is it seems like the older she is getting,
the more she has episodes or crisis. It’s painful. Her
mother tells me she can’t even get out to walk, and
she’s only 13 years old. She has had bouts in the
hospital. They have to put her on morphine, so you
can imagine with a little body like hers, it affects her
psychologically.
Another spoke about the pain he witnessed when a
family member went into a crisis stating, “I do know it’s
very painful because he used to ball up and just fall on the
floor, and he’d be in a ball crying.” One participant who
was a junior high school teacher described her interaction
with a student diagnosed with SCD.
If you’ve ever watched a child suffer from sickle
cell, I had a student who had sickle cell. I was her
teacher. It broke my heart to watch her sit in my
classroom and the pain that she suffered, and to
know she suffered all her life and even sadder, she
knew she was never going to see 50 the way her
health was.
Sub-Topic: Difference between Disease and Trait
In addition to articulating an understanding of SCD,
several focus group participants were able to identify the
cause of symptoms and the differences between disease and
trait. Some were able to connect the name of the condition
to the abnormal shape of the cell. Statements included “…
From what I understand, it’s like your cells are an abnormal
shape (Male)” and “The shape of the cell is like a moon or
crescent, and it stops the flow of the blood (Female).”
Participants distinguished SCD from SCT by the presence
or absence of symptoms and again relied on personal
experience to make this distinction.
I had a friend who had sickle cell, and she would go
into a crisis quite a bit. She didn’t survive. She passed
away in her early 30s, and in her family there were a
number of people who had the trait, and when you
asked the question, the main thing I thought of was
the trait doesn’t go into crisis situation. (Female)
Sub-Topic: Inheritance
Uncertainty and misconceptions emerged as participants
attempted to make sense of the pattern of disease and trait
seen within a family. Some individuals questioned why
only some children have disease when each parent has trait.
You would think, at least I do, if the mother or the
father or both have it, then all the siblings would have
Long et al.
it. Why is it maybe just one out of three or four may
have it and the other ones not? (Male)
Other participants were uncertain as to why SCD would
appear for the first time in a family.
My grandson’s cousin was the first in our family. I
mean it was a surprise to me that his first cousin was
born with sickle cell and then later on, my grandson,
my daughter’s son, has a trace of sickle cell. So I
don’t know where that came from. It was surprising to
me that he has the trait. I am clueless as to whether he
received that from his father, because I know of no
one on my side of the family that ever had that that I
am aware of. (Female)
One woman observed a pattern in her family where
only females had SCT. “I have the sickle cell trait, and
when you were talking about different family members
that have it, it seems like the females in my family have
it. I had the trait, my daughter, my sister.” Participants
did not articulate what they believe the chances are to
have a child with SCD when each parent has trait, nor
did they discuss the chance for a child to inherit SCT
when one or both parents have trait.
Sub-Topic: Social Issues
Participants commented on intimate knowledge of
tension and stress within a family caring for a child with
SCD.
I watch my friend. I ache for her because unfortu-
nately we both work for a major corporation—I won’t
mention—but the area she works in they don’t show
sympathy for the time she needs to be off when her
daughter is in the hospital, and she’ll spend the night
at the hospital and she’ll go to work. Her husband has
the type of job that he can adjust his schedule a little
bit, so he’ll be there during the day while she goes to
work, and she goes home, washes up, goes to the
hospital, spends the night at the hospital, gets up, and
goes to work. (Female)
Another participant focused on the helplessness a family
feels when a child with SCD is in pain.
…And the drain it takes on family members as
parents to know something is wrong with your child
and you’re helpless, and what I see my girlfriend go
through at times, there is nothing she can do to ease
the pain and discomfort. (Female)
Other social issues that were addressed by participants’
conversations focused on the stress an individual with SCD
may experience as he/she interacts with the health care
profession. Awoman described the difficulty an adult may
have acquiring pain medication from a skeptical physician
in order to treat his/her SCD.
Sometimes the medical profession is not very sym-
pathetic, and they think the young people want the
drug and there is really no pain. So there are a whole
lot of things that are going on. They think you just
want some morphine drip. Come on! You want to be
out doing things you want to do and being active just
like your other friends, but because you are in the
hospital and they can’t pin point the pain. It’s almost
like back pain. You can’t really pin point it.
Topic: Barriers to Education and Awareness of Sickle Cell
Disease
Sub-Topic: Personal Barriers
Avoidance
Awoman expressed a common sentiment repeatedly heard
during each focus group. “Sometimes people don’t want to
know. They like to stay ignorant to the fact. If I don’t know
it, then it can’t hurt me.” A male participant stated:
I believe in not worrying about something. If you start
thinking about these different diseases coming your
way, sooner or later it’s going to smack you right in
the face. I don’t deal with it. When it happens, it
happens.
The desire to not consider the possibility of a disease is
not unique to sickle cell. One participant described her
experience with relatives who did not want to acknowledge
the risk for polycystic kidney disease in the family.
I have to be real strong even with the rest of the
family. This is something I have to do. I have brothers
and a sister. ‘I don’t want to know. I don’t want to
know.’ But like I said, I want to save my grand-
children. I am trying to protect my grandchildren. I
was trying to protect my children. It was not
something that I went into. I was forced into it.
Some participants described having an accurate knowl-
edge of the risk for a particular disease in the family but
openly denied its impact on their personal health. “Even
those things that the family has experienced, I don’t worry
just because they experienced them. It doesn’t mean my
family or I am going to experience it.” Another participant
states:
Sometimes we take on different things that we hear
and we accept, and sometimes the doctors will impart
things and make you believe that you are going to
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have this. No, I am not going to have this, and I am
not accepting what you are saying, and I am not going
to receive it. My grandmother had that, and yes my
mother had that, but that does not mean I am going to
have that. Now you may want me to have this, but I
am giving this back to you. I am not having cancer. I
am not accepting diabetes, and I am not claiming it
from this point on, so I am giving it back to you.
(Female)
Overwhelming Responsibilities
For young mothers, there was a sense that other daily
challenges take precedence over thinking about newborn
screening for SCD and SCT.
I believe a lot of our people have other things to
worry about besides whether my kid has sickle cell.
There are other issues like whether they are going to
have food on the table or whether their mother is a
drug addict. A lot of these kids are out there. They are
raising themselves because their parents are drug
addicts. They have other issues that are more
important to them than this. (Female)
Sub-Topic: Family Barriers
Absence of Open Communication About Health Issues
The absence of open communication about familial risk for
disease was identified as a barrier to health awareness and
education.
I’ll give you an example. My dad is 82. I just found
out about a year ago that my dad is the oldest brother
out of 6 siblings. My cousin is doing a family history,
so he called. He is a radio announcer in Baltimore. He
said ‘I’m going to do a family history and ask
everybody what school they went to, who they
married, and so forth.’ So I asked my dad. He said,
‘Well you know one of my brothers has diabetes and
my other brother has this, and my sister has this, but
don’t tell them I told you so.’ What I am saying is if
his brothers and sisters have these illnesses and he
doesn’t want me to know, how are their children
supposed to know? How is this going to go down
from generation to generation? (Female)
Participants were aware that a lack of family discussion
about risk for disease prevents future generations from
making informed decisions about their health. A participant
shared the following, “I think a lot of times most families
don’t sit together to talk about family history, and those
things pass down from generation from ancestors, and so
once you learn your family history, then you can have a
better picture (Female).”
Shame
The shame and stigma of disease within a family was
identified as a hindrance to knowledge and prevention. “I
think more families are talking more about it. It’s not seen
as you have to be ashamed about it (Female).”
Sub-Topic: Societal Barriers
Distrust
Participants described a lack of trust in the medical
establishment due to past abuses directed against African-
Americans. Participants discussed the Tuskegee Syphilis
Study. As one participant said, “Like the Tuskegee experi-
ments, our parents pass that on to their children and
grandchildren. That is don’t trust the police, don’t trust the
medical [profession]. That is passed on (Female).” This
distrust and fear was also evidenced in young focus group
participants. One young woman stated:
I am praying on it because it is really crazy the way
they use black people for experimentation and then
they don’t teach you a doggone thing in the schools
about what is going on and it probably has to occur
with the people…start speaking up and saying
something.
Minimal Media Attention
Participants explained the belief that there is not enough
SCD activism and health education within the community
and that leads to minimal media attention on the condition.
I remember in the 80’s it was on billboards. That was
the first time I had heard about it. I came back here
from some place else and it was on billboards. They
had some celebrities on TV talking about it. Then
after the 80’s, you don’t hear about it anymore.
(Females)
Participants believe that other public health issues such
as HIV/AIDS are given more media attention within the
community.
It’s [sickle cell] a disease that affects mostly African
Americans and then I’ll bring this up. AIDS affects
everyone. Every day, every time you can see radio,
print, TV about AIDS and HIV ‘Get tested.’ How
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come nobody is out in the communities saying to
African Americans put it [sickle cell] on TV. It doesn’t
matter whether it affects Caucasians or Mexicans or
whoever. Why isn’t it out there? Like I said, I didn’t
know about it until I was 30 something years old.
(Female)
Minimal Physician Discussion
Participants believe that a lack of awareness also stems
from physicians not providing the necessary information
about sickle cell. Throughout the conversations, partic-
ipants expressed their frustration with their lack of
knowledge and felt that their physician should have
supplied the information regardless of whether or not the
patient asked about SCT testing.
You go in the doctor’s office waiting for him. You see
‘If you have diabetes, take your shoes and socks off.’
You see mammograms. You see all these different
things on the wall. There are flu shots. I don’t see
anything about sickle cell. I don’t see anything about
lupus. I see more about stem cell research which I
have no clue really what it is but I see a lot of it and
bone marrow transplants for African Americans
because that is so rare. If it only affects a certain
group of individuals, be it minorities, then it seems
like there is not a lot of information out there and they
[physicians] don’t care. (Female)
Lack of Knowledge Among Teenage Mothers
Participants felt that teenage mothers were unaware of the
risk for SCD.
Mothers are not physicians and so you can’t expect
them to be informed and know what questions to
ask and so I think if you are a professional, a
concerned physician, then you will supply that kind
of information to them and particularly young
mothers. Girls are having babies at 11 and 12, 15,
18 years old and they don’t have any questions to
ask. They don’t know and so it’s the responsibility
of the physician. (Female)
I think also with mothers being so young today they
are not aware. What do they know about sickle cell?
Adults don’t know about it. With the age of the
mothers being so young, they don’t know and a lot of
times the doctors take advantage of that, and they may
just mention it, but it will blow over. This is a young
mother. She is probably concerned about how she is
going to take care of this child—fearful and fright-
ened. So a doctor probably knows that, but that parent
doesn’t really focus on that. (Female)
Discussion
Research among African-Americans indicates this popula-
tion perceives SCD to be a serious disease and SCT
screening an important intervention. However, studies have
consistently demonstrated a lower than desired uptake of
SCD education, inadequate knowledge regarding personal
and family trait status, and a low perceived susceptibility of
giving birth to a child with the disease (Acharya et al. 2009;
Gustafson et al. 2007; Kladny et al. 2005; Midence et al.
1994; Treadwell et al. 2006; Wright et al. 1994). In this
study, we examined general attitudes and beliefs regarding
genetics and genetic testing including prenatal testing and
newborn screening among a unique sample of African-
American adults; we used this information as the founda-
tion to more specifically assess attitudes and beliefs
regarding SCD and perceived barriers to SCD education
and awareness.
This study took a qualitative thematic approach to
provide a deeper understanding of why African-
Americans perceive SCD to be a serious disease but
have a low perceived susceptibility to have a future child
with SCD and lower than desired awareness and uptake
of SCD education. As stated previously, past experiences,
beliefs, and attitudes influence the way individuals
approach new knowledge, learning, and decision-
making (Catz et al. 2005). By discerning attitudes and
beliefs about genetics and common genetic testing
scenarios among a unique sample of African-Americans,
we were able to then integrate this information into our
understanding of participants’ attitudes and beliefs toward
SCD and perceived barriers to SCD education and
awareness.
Attitudes and Beliefs Regarding Prenatal Testing
and Newborn Screening
Both prenatal testing and newborn screening were generally
viewed as acceptable forms of genetic testing by focus
group participants. Although with prenatal testing both
concerns and potential risks were raised, the overall
response was that there is a significant benefit to having
information. Participants described how this form of testing
allows one to be aware of issues for a future child and make
informed choices about continuing or terminating a
pregnancy. As evidenced by participants’ responses, termi-
nation is an acceptable choice in situations that involve a
medical issue affecting the fetus.
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Prenatal testing was a relatively familiar concept for the
majority of focus group participants. They drew from and
cited their own personal experiences or those of friends and
family members. Newborn screening was a much less
familiar form of testing. Participants fell into one of three
knowledge categories when discussing newborn screening:
those who were unaware, those who had accurate but
incomplete knowledge, and those who had misinformation.
After a definition of newborn screening was provided by
the moderator, conversational flow about this form of
testing occurred. Very few participants cited personal or
second-hand experiences with newborn screening or its
outcome. Interestingly, newborn screening was viewed as
only beneficial; participants identified no risks or concerns
regarding obtaining this type of genetic knowledge. This
may be due to participants’ less familiarity with newborn
screening when compared to prenatal testing.
The general positive acknowledgement and noted bene-
fits of prenatal testing and newborn screening and the
acceptance of termination in a situation where a medical
issue is affecting the fetus are noteworthy. These findings
make it less likely that negative attitudes and beliefs about
genetic testing or the potential outcome of genetic testing
(termination) are influencing the lower than desired uptake
of SCD education, inadequate knowledge regarding per-
sonal and family trait status, and low perceived suscepti-
bility of giving birth to a child with the disease. It should be
emphasized, however, that qualitative data are not intended
to be generalized to the population of interest. Therefore,
such conclusions are tentative.
Reliance on Experience
When discussing the resources participants access for
information about genetics, very few individuals spoke of
seeking out information from the library, books, or internet
resources. Similarly, a quantitative study by Nicholson and
colleagues (2003) examining the relationship between race
and women’s use of health information resources found that
African-American women had 50–70% less odds of using
print news media, computer resources, or health organiza-
tions for information when compared to Caucasian women.
In the current study, focus group participants reported
relying on what they knew from on the job experience,
participation in research studies, stories they had witnessed
on television, and discussions with physicians, family, and
friends. Prior research on the information seeking behaviors
of African-Americans has similarly demonstrated the
importance of personal sources such as family, friends,
and the church (Acharya et al. 2009; Nicholson et al. 2003;
Talosig-Garcia and Davis 2005).
As participants discussed complicated issues such as
genetic disease and genetic testing in the prenatal period,
their reliance on personal or secondhand experiences
appeared to help them to have a more robust understanding
of the potential benefits and risks or concerns regarding
prenatal testing. Their greater exposure to prenatal testing
and the stories of friends and family members seemed to
give them more confidence in their knowledge of the topic
and their knowledge was often accurate.
When discussing newborn screening, participants cited
fewer personal or secondhand stories. Their knowledge and
accuracy concerning this topic were also reduced in
comparison to prenatal testing. However, once given
information on newborn screening, participants conversed
about the potential benefits of this form of testing.
Throughout focus group discussion it was clear partic-
ipants possessed an appropriate understanding of the
severity of SCD symptoms and clinical course but in
general were unaware or misinformed about the inheritance
of the condition. Similar to previous research, individuals
accurately identified that SCT and SCD travel through
families but did not understand the risk to children
conceived by parents when one or both have SCT (Acharya
et al. 2009; Gustafson et al. 2007; Treadwell et al. 2006).
In the current study, it was noted that reliance on
personal experiences with family and friends had a negative
impact on the understanding of the inheritance of sickle cell
for some participants. By concentrating on the experiences
of one situation, individuals misinterpreted the inheritance
of SCD which led to inaccurate risk perception. This could
be a factor contributing to African-Americans’ low per-
ceived susceptibility to have a child with SCD.
Knowledge of Sickle Cell Trait Status
Similar to previous research, the current study found that a
majority of focus group participants did not know their
personal SCT status or that of their spouse/partner and
children (Midence et al. 1994; Wright et al. 1994). Forty-
two percent of the 35 participants knew their personal SCT
status. This percentage was higher than expected, but given
that 97% of participants had health insurance and only 17%
had difficulty seeing a physician due to cost, individuals
may have had greater interaction with the medical profes-
sion and access to testing for SCT. This larger than expected
percentage may also be due to participants’ age. The
majority experienced their childbearing years during the
early 1970s which is the time period when federal funding
for state sickle cell screening programs was available
(Markel 2006).
Interestingly, the majority of focus group participants did
not know the SCT status of their spouse or partner. This
finding may be in part reflective of the theme which
emerged from focus group discussion regarding the lack of
family communication about health conditions. However,
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partners may not have had testing in order to know their
status. Additionally, the majority of participants did not
know their child’s SCT status. This finding may be rooted
in the fact that many participants are past their childbearing
years, and newborn screening for sickle cell did not become
mandatory in Pennsylvania until 1990 (Olney 2000). As
participants indicated throughout focus group discussions,
parents of older children may not have known to ask their
physician to perform SCT screening due to a lack of
awareness of the risk for the condition. Additionally, family
physicians may not have explained the importance of SCT
screening to their African-American patients or inquired
about the results of newborn screening for sickle cell.
Barriers to Sickle Cell Disease Education and Awareness
Participants identified specific personal, familial, and
societal barriers to awareness that are at work in their daily
family and community lives. The societal barrier described
as distrust of the medical profession due to past abuses is an
issue deeply rooted in African-American culture. A similar
theme was reported in focus groups conducted by Tread-
well and colleagues (2006) as well as Zimmerman and
colleagues (2006). Additionally, a qualitative study of
African-American community members’ attitudes toward
medical research found that the Tuskegee syphilis study
was an important negative factor in the decision to
participate in research for older individuals, while distrust
of physicians was a personal barrier for both younger and
older participants (Hamilton et al. 2006).
Participants also feared acknowledging the risk for a
health condition such as sickle cell to occur, resulting in
their use of coping mechanisms such as avoidance and
denial. Several individuals reported believing that simply
thinking about a risk would cause the disease to develop in
themselves or a family member. This was an interesting
finding considering that participants possessed a high level
of education in comparison to the larger African American
community from which they were drawn.
African-Americans’ denial of multifactorial health con-
ditions has been documented in the literature as well.
Specifically, denial has been associated with diseases which
have a significant racial health disparity such as prostate
cancer, heart disease, breast cancer, and stroke (Gullate 2006;
King et al. 2001; Richardson et al. 2004; Rucker-Whitaker et
al. 2006). These studies have identified anxiety and
repression of fear as potential causes of African-Americans
denying their risk for disease (Gullate 2006; King et al.
2001; Richardson et al. 2004; Rucker-Whitaker et al. 2006).
A study by Gullate (2006) documented this denial as “If you
name it, you claim it.” This complex sentiment is similar to
the thoughts expressed in the present focus groups. The
explanation for this belief is difficult to encapsulate and
attribute simply to denial or avoidance. It is likely more
nuanced than this. From a cultural perspective, this belief
might be viewed as a complicated use of self-justification to
express optimism that one can cope and/or overcome a
challenging health situation.
The barriers of fear, denial, and a societal/cultural lack of
awareness may be connected to the absence of open
communication about health issues within some African-
American families. Participants stated they were limited in
their knowledge of family disease risk because older
generations did not want to discuss a personal or family
history of health conditions, and issues of personal and
family shame prevented relatives from discussing their own
health issues. Participants also brought attention to the lack
of family conversation about SCT status and family history
of SCD. They believe that the absence of discussion causes
future generations to have misconceptions about sickle cell
that can lead them to fear and deny their family history. The
absence of family communication about sickle cell may
also be a factor in the lack of knowledge among teenage
parents. If parents do not talk with their children about SCT
status and the risk for disease, then a lack of awareness may
be perpetuated into the next generation.
Study Limitations
The study is limited by the method of recruitment and
sampling of African-American community members. Indi-
viduals who participated in this research project were self-
selected and many spoke of the importance of giving back
to the HBFP by contributing their time to research. The
majority of participants were recruited from the MRRD and
therefore, already inclined to participate in research. This
was a unique sample of the African-American population.
Moreover, as mentioned previously, qualitative data are not
intended to be generalized to the larger African American
population.
The vast majority of the sample were female, which is
consistent with the larger HBFP population. The under
representation of African American men within the HBFP
is not uncommon for other health and wellness programs.
Women are consistently the early adopters of medical and
health related information. Studies examining the barriers to
African-Americans’ participation in research have demon-
strated that men and women differ in the types of barriers
described and the impact those barriers have on participa-
tion (BeLue et al. 2006; Hoyo et al. 2003). Specifically,
African-American men participating in qualitative studies
have been found to be concerned about the costs and time
commitment of research participation (BeLue et al. 2006;
Hoyo et al. 2003). Additionally, men have been found to
have a low interest level and participation rate in research
because of a lack of knowledge and awareness about the
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process of research (Hoyo et al. 2003). In contrast, African-
American females have described barriers such as the
researcher-participant relationship and the need to have the
researcher make the participant feel comfortable (BeLue et
al. 2006). Women may have felt more comfortable than
men attending the focus groups because they had previ-
ously met with the moderator and assistant to the moderator
through other HBFP events, and they were familiar with the
Kingsley Association, which also has services and targeted
programming for school aged children.
The median age of focus group participants was beyond
the typical reproductive years. Though discussion of topics
such as newborn screening and prenatal testing may be
more appropriate for individuals of childbearing age, the
overall goals of the project were attained by capturing the
opinions of diverse members of the community. It is also
important to point out that as evidenced by group
conversation SCD pervades community life regardless of
age. Many of the older focus group participants were
primary caretakers for grandchildren and had intimate
knowledge of prenatal testing, newborn screening, and
sickle cell.
Participant income levels were representative of the area
when compared to data collected by the US Census in
conjunction with information compiled by the University of
Pittsburgh RCEMHD and the Allegheny County Health
Department (Robins 2005). In the current study, all
participants completed high school with the majority
completing post-high school education which is greater
than the educational level previously described in this
community (Robins 2005). Although there was a difference
in educational background between focus group partici-
pants and those living in the larger community, this study
was able to demonstrate that a sample of African-American
individuals with a high level of education have both
inaccurate and incomplete information about newborn
screening and sickle cell inheritance and risk. Therefore,
one could speculate that a sample of individuals with less
advanced education would have less accurate knowledge of
these topics.
Practice Implications
The results of this study highlight the importance of
identifying trusted sources of information within the
African-American community when designing strategies
to address barriers to SCD education and awareness.
Locating and establishing relationships with these trusted
sources is one potential approach that would allow genetic
counselors in the clinical and community outreach settings
the opportunity to formulate partnerships to promote SCD
education. As noted by this study and others, community
physicians, community leaders with an association to a
medical or health profession, and the church are often
identified as trusted sources. Collaborating with these
sources to promote or host educational events and distribute
print and internet based materials creates the opportunity to
increase the trust and rapport which have already been
established between the community and trusted sources.
Community based events hosted by an identified
neighborhood health center, church, or other trusted
community organization could focus on providing active
learning. The goal of this design would be to allow
participants the opportunity to come together and learn in
a familiar community environment and gain insights and
experiences from an interactive program. Guest speakers
could include families who have a child with SCD and
physicians or genetic counselors involved in sickle cell
screening or caring for individuals with SCD. The personal
story of a family or individual with sickle cell would
provide participants with the experience and observation to
draw on as they attempt to understand the condition and
explain it to other family members and friends. At the same
time, a physician and/or genetic counselor can draw
attention to specific aspects of the patient or family’s story
and clarify issues regarding inheritance, testing, and
screening.
Genetic counselors in the clinical setting may also find
utility in identifying their clients’ trusted sources of
information and personal experiences with SCD and SCT.
When SCD and/or SCT is mentioned in the reporting of the
family history or when the patient or partner’s ethnic
background is consistent with an increased risk of SCT, the
disease, inheritance and risk, and testing should be
addressed. However, before providing a description of the
autosomal recessive inheritance pattern of this condition,
we would suggest first asking the client, couple, or family
how they believe sickle cell is inherited and then asking
why they believe this pattern exists. The answers may
provide useful opportunities to address misinterpretations
of disease inheritance and validate those responses which
accurately describe risk. This conversation may also invite
discussion of barriers to SCT testing for the client and
partner and allow the genetic counselor the opportunity to
gather insight into the client’s belief system and coping
mechanisms and to identify individualized strategies for
recognizing and overcoming these barriers.
One particularly noteworthy barrier in the current study
was the lack of familial communication about health issues.
Identification of this barrier presents an opportunity for
genetic counselors to play an important role in facilitating
and enhancing family discussions. Genetic counselors
could use a variety of strategies to help diminish this
communication barrier such as offering to meet with
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multiple members of a family, composing family letters,
providing tools to create a family health history, and
partnering with trusted community sources to promote
family discussion.
Research Recommendations
This study did not explicitly assess whether focus group
participants had any previous experiences with genetic
counseling for sickle cell in the preconception, prenatal, or
pediatric setting. Future research studies could examine and
compare the knowledge and understanding of the differ-
ences between SCD and SCT and risk perception among
individuals who have undergone genetic counseling in one
or more of these settings in order to determine the most
effective method or combination of methods for providing
education and the extent to which that information was
used in reproductive decision making.
Additionally, if a community education intervention could
be designed and implemented, the effectiveness of this
intervention would merit investigation. It would be of interest
to determine individuals’ motivations for participating in the
intervention, whether the information is retained at various
time points, the accuracy of the information retained, whether
or not the information was shared with children, partners,
family, and friends, and if the information was utilized by the
participants in reproductive decision making.
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Appendix
We thank you for participating in this focus group. This survey
is to gather information about the community’s interactions
with genetics, genetic testing, and sickle cell. If there is a
question that you do not feel comfortable answering, you can
skip it and continue on. Please answer the following questions
to the best of your ability. The survey should take approx-
imately 10minutes.Wewould like to thank you in advance for
your willingness to participate in this study.
Section 1: General Information
1) What is your age?
__ __ age in years
2) What is your gender?
1 Male
2 Female
3) Are you Hispanic or Latino?
1 Yes
2 No
3 Don’t know
3a) Which one or more of the following would you say is
your race? (Check all that apply)
1 White
2 Black or African American
3 Asian
4 Native Hawaiian or Other Pacific Islander
5 American Indian, Alaska Native
6 Other [specify] __________________________
4) What was the total household income from all sources
last year?
1 Less than $10,000
2 Between $10,000 and $20,000
3 Between $20,001 and $35,000
4 Between $35,001 and $50,000
5 Between $50,001 and $75,000
6 Greater than $75,000
5) What is the highest grade or year of school you
completed?
1 Grades 8 or less (Elementary)
2 Grades 9 through 11 (Some high school)
3 Grade 12 or GED (High school graduate)
4 College 1 year to 3 years (Some college or technical
school)
5 College 4 years or more (College graduate or post-
graduate)
6 Graduate level (Masters or PhD)
6) How would you rate your knowledge on genetics?
1 Excellent
2 Very good
3 Good
4 Fair
5 Poor
7) How would you describe your general health?
1 Excellent
2 Very good
3 Good
4 Fair
5 Poor
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8) Do you smoke?
1 Yes
2 No
9) How would you describe your weight?
1 Underweight
2 Healthy weight
3 Overweight
4 Obese
10) Do you have one person you think of as your personal
doctor or health care provider?
1 Yes, only one
2 More than one
3 No
4 Don’t know / Not sure
11) Was there a time in the past 12 months when you needed
to see a doctor but could not because of the cost?
1 1 Yes
2 No
3 Don’t know / Not sure
12) Do you have any kind of health care coverage,
including health insurance, prepaid plans such as
HMOs, or government plans such as Medicare?
1 Yes
2 No
3 Don’t know / Not sure
Section 2: Sickle Cell and Newborn Screening
13) Do you know your sickle cell trait status?
1 Yes
2 No
3 Don’t know
14) Do you know your partner/spouse’s sickle cell trait status?
1 Yes
2 No
3 Don’t know
4 Not applicable
15) Do you have children?
1 Yes
2 No
16) If you answered “Yes” to the previous question, do
you know your child’s sickle cell trait status?
1 Yes
2 No
3 Don’t know
17) Do you know someone with sickle cell disease?
1 Yes
2 No
3 Don’t know
18) Do you know someone with sickle cell trait?
1 Yes
2 No
3 Don’t know
19) Do you know someone that was found to have sickle
cell disease or trait by newborn screening?
1 Yes
2 No
3 Don’t know
Focus Group Guide
I. Introduction (10 min)
Good afternoon/evening and welcome to our session.
Thank you for taking the time to join our discussion on
genetics, genetic testing, and sickle cell. My name is ____
and I am with the Healthy Black Family Project from the
Center for Minority Health at the University of Pittsburgh.
Assisting me is _____ who will be taking notes on the
conversation during the focus group. Please begin by
filling out the survey in front of you by circling your
answers. We will begin when everyone has completed this
form.
You have been invited because you are a member of the
Healthy Black Family Project and your opinions on
genetics, genetic testing, and sickle cell are important to
us. Our research team is trying to understand the attitudes
and beliefs of African-Americans toward these issues. We
would like to hear your opinions. We will ask you a
number of questions and we need your honest thoughts
and ideas. Please feel free to share your point of view
especially if it is different from what others have said.
There are no wrong answers, only different points of view.
Now, let me share some ground rules. We want to make
sure that everyone feels comfortable expressing his or her
own opinion. We ask that you are respectful of everyone
by listening to one another and waiting until the person
speaking has finished before you begin. Please do not
have side conversations with your neighbor during the
discussion. All of your comments are helpful and would
provide us with useful information. We have placed cards
on the table in front of you to help us remember your
names during the focus group.
As you have probably noticed, we have a microphone
on the table. We will be tape recording our discussion so
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that we don’t miss any of your comments. To assure you
of your confidentiality, we will only be using the names
you selected for today and will not use any names in our
final reports.
The group discussion will last about 2 hours so please
feel free to enjoy your meal as we begin. We will have a
10-minute break. You should have already completed the
brief survey and we will collect it before we begin.
II. Assessing Knowledge of Genetics
Question 1
Where do you receive trusted medical information?
Probe: From a Physician, Nurse, Pharmacist,
Friend/Family member, TV, radio, newspaper,
internet, seminar, etc.?
Probe: Why is this your most trusted source of
medical information?
Question 2
What comes to mind when you hear the word
“genetic” or “genetics”?
Probe: Where have you heard this word? Who has
used the word?
Probe: How do you think “things” are passed
down to or inherited from one generation to
another? Why?
III. Assessing Knowledge of Prenatal Testing and New-
born Screening for Genetic Conditions
Question 3
When you hear the words “prenatal testing” what
does it mean to you?
[Definition shared if no one answers: Prenatal
testing is testing performed on the developing baby
while a woman is pregnant. It can be used to
gather information about genetic health conditions
in the baby.]
Probe: Are there benefits of prenatal testing? What
are these benefits? Why?
Probe: Are there risks of prenatal testing? What are
these risks? Why?
Probe: Would you want to know if your baby had a
genetic condition?
Question 4
When you hear the phrase “newborn screening”
what do you think of?
Probe: This is also referred to as the “heel stick test.”
[Definition shared if no one answers: Newborn
screening is testing performed on the newborn baby
before leaving the hospital. A small sample of
blood is obtained from the baby’s heel to test for
rare genetic diseases that are life-threatening but
where early intervention or treatment has an impact
on disease outcome.]
Probe: Where have you heard the phrase used?
Probe: Who has used it?
Probe: Under what conditions or circumstances
has it been used?
Probe: What kind of information would you like to
know before a child’s blood is taken?
Probe: Are there benefits of newborn screening?
What are these benefits? Why?
Probe: Are there risks of newborn screening? What
are these risks? Why?
Probe: Would you want to know if your child had a
genetic condition?
IV. Assessing Understanding of Sickle Cell Disease
Question 5
What is sickle cell disease?
Probe: Where have you heard this condition
discussed?
Probe: What is the difference between the sickle
cell disease and sickle cell trait?
Probe: Do you think one is more serious than the
other? Why?
Probe: How does someone get sickle cell?
V. Assessing Perceived Risk of Sickle Cell
Question 6
Earlier we talked about how things are inherited or
genetics, do you think there is a risk in your family to
have a future child or grandchild with sickle cell trait?
Do you think there is a risk in your family to have a
future child or grandchild with sickle cell disease?
Probe: Why or why not?
VI. Assessing Opinions on Sickle Cell and Newborn
Screening
Question 7
Scenario: It is three days after the birth of your child
and you just found out your child has sickle cell
disease. How helpful would this information be to you?
If your child had sickle cell trait, how helpful
would this information be to you?
Probe: What would you do with this information?
VII. Assessing Ideas on Community Education Interventions
Question 8
How can the community help parents become
more aware of information about sickle cell?
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VIII. Closing
Thank you for your time and energy given to this
discussion. It was a pleasure listening to your
thoughts and opinions. We will need your signature
to indicate you have received your $25 gift
certificate before you leave.
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